Evotec SE
EVOTFOTCHealthcare● Active
$6.69
+$0.00(+0.00%)
Market Cap$1.2B
P/E Ratio—
52W High$8.58
52W Low$4.725
Evotec SE (EVOTF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EVOTF · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
-$0.80
Est. -$0.28 · -181.6%
Revenue
$0.18B
Est. $0.20B · -10.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
EVOTF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | $0.02 | — | — | — | $0.20B | — |
| ▼ Q2 FY2026 | May 6, 2026 | -$0.28 | -$0.80 | -181.6% | $0.18B | $0.20B | -10.0% |
| ▼ Q2 FY2026 | Apr 8, 2026 | $0.36 | $0.09 | -74.2% | $0.30B | $0.28B | +4.5% |
| ▼ Q4 FY2025 | Nov 5, 2025 | -$0.16 | -$0.28 | -82.7% | $0.19B | $0.24B | -20.0% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$0.15 | -$0.29 | -93.2% | $0.20B | $0.20B | +0.0% |
| ▼ Q2 FY2025 | May 6, 2025 | -$0.09 | -$0.18 | -105.5% | $0.20B | $0.23B | -14.6% |
| ▼ Q2 FY2025 | Apr 17, 2025 | $0.03 | -$0.24 | -867.9% | $0.23B | $0.23B | -1.2% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -$0.12 | -$0.25 | -100.1% | $0.20B | $0.22B | -8.3% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
$0.02
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Miss
EPS Actual
-$0.80
EPS Est.
-$0.28
EPS Surpr.
-181.6%
Revenue
$0.18B
Q2 FY2026
Apr 8, 2026Miss
EPS Actual
$0.09
EPS Est.
$0.36
EPS Surpr.
-74.2%
Revenue
$0.30B
Q4 FY2025
Nov 5, 2025Miss
EPS Actual
-$0.28
EPS Est.
-$0.16
EPS Surpr.
-82.7%
Revenue
$0.19B
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$0.29
EPS Est.
-$0.15
EPS Surpr.
-93.2%
Revenue
$0.20B
Q2 FY2025
May 6, 2025Miss
EPS Actual
-$0.18
EPS Est.
-$0.09
EPS Surpr.
-105.5%
Revenue
$0.20B
Q2 FY2025
Apr 17, 2025Miss
EPS Actual
-$0.24
EPS Est.
$0.03
EPS Surpr.
-867.9%
Revenue
$0.23B
Q4 FY2024
Nov 6, 2024Miss
EPS Actual
-$0.25
EPS Est.
-$0.12
EPS Surpr.
-100.1%
Revenue
$0.20B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.12 | $0.12 | $0.13 | 1 |
| Q3 FY2027 | $0.09 | $0.09 | $0.09 | 1 |
| Q2 FY2027 | $0.06 | $0.06 | $0.06 | 1 |
| Q1 FY2027 | $0.04 | $0.04 | $0.04 | 1 |
| Q4 FY2026 | $-0.02 | $-0.02 | $-0.01 | 1 |
| Q3 FY2026 | $-0.10 | $-0.10 | $-0.10 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q2 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q1 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q4 FY2026 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2026 | $0.2B | $0.2B | $0.2B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 6, 2026 | -181.6% | $5.24 | $6.69 | +27.67% |
| ▼ Q2 FY2026 | Apr 8, 2026 | -74.2% | $5.24 | $5.24 | +0.00% |
| ▼ Q4 FY2025 | Nov 5, 2025 | -82.7% | $8.01 | $8.01 | +0.00% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -93.2% | $8.52 | $8.52 | +0.00% |
| ▼ Q2 FY2025 | May 6, 2025 | -105.5% | $8.27 | $8.27 | +0.00% |
| ▼ Q2 FY2025 | Apr 17, 2025 | -867.9% | $8.27 | $8.27 | +0.00% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -100.1% | $6.77 | $6.77 | +0.00% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -667.8% | $6.57 | $6.57 | +0.00% |
Q2 FY2026+27.67%
Report Date
May 6, 2026
EPS Beat/Miss
-181.6%
Price Before
$5.24
Price After
$6.69
Q2 FY2026+0.00%
Report Date
Apr 8, 2026
EPS Beat/Miss
-74.2%
Price Before
$5.24
Price After
$5.24
Q4 FY2025+0.00%
Report Date
Nov 5, 2025
EPS Beat/Miss
-82.7%
Price Before
$8.01
Price After
$8.01
Q3 FY2025+0.00%
Report Date
Aug 13, 2025
EPS Beat/Miss
-93.2%
Price Before
$8.52
Price After
$8.52
Q2 FY2025+0.00%
Report Date
May 6, 2025
EPS Beat/Miss
-105.5%
Price Before
$8.27
Price After
$8.27
Q2 FY2025+0.00%
Report Date
Apr 17, 2025
EPS Beat/Miss
-867.9%
Price Before
$8.27
Price After
$8.27
Q4 FY2024+0.00%
Report Date
Nov 6, 2024
EPS Beat/Miss
-100.1%
Price Before
$6.77
Price After
$6.77
Q3 FY2024+0.00%
Report Date
Aug 14, 2024
EPS Beat/Miss
-667.8%
Price Before
$6.57
Price After
$6.57
Avg Miss Reaction+3.46%
Beat Rate0 / 8 quarters
Largest Move+27.67% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EVOTF ends December
Evotec SE (EVOTF) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $-0.80 — missing the analyst consensus of $-0.28 by -181.6%. The next EVOTF earnings date is expected around September 1, 2026.
Each quarter, investors track EVOTF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EVOTF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EVOTF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EVOTF earnings · 5 questionsEvotec SE's next earnings report is expected around September 1, 2026. EVOTF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EVOTF historically reports after market close (AMC).
EVOTF earnings datewhen is EVOTF earningsEVOTF next earnings datewhen does EVOTF report earningsEVOTF earnings calendar
▸ Source: FMP · Evotec SE SEC filings · US GAAP · Evotec SE SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026